newsfilter
← Latest News
GlobeNewswire·

Aerpio Reports Third Quarter 2020 Financial Results and Provides Business Update

Enrollment completed in the 28-day Phase 2 razuprotafib glaucoma trial; topline data expected to be reported in December 2020 or possibly in early January 2021Initiated second clinical trial to...